AbbVie Inc (ABBV)
Debt-to-equity ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 3,325,000 | 10,360,000 | 17,254,000 | 15,408,000 | 13,076,000 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $3,325,000K
= 0.00
The debt-to-equity ratio of AbbVie Inc has remained consistently at 0.00 from December 31, 2020, to December 31, 2024. This indicates that the company has not utilized debt financing to fund its operations but has relied primarily on equity for its capital structure during this period. A debt-to-equity ratio of 0.00 suggests that the company is not employing financial leverage to grow its business and is maintaining a conservative approach to capitalization. It signifies a potentially low financial risk associated with the company's operations, as there is no significant debt burden relative to its equity base.
Peer comparison
Dec 31, 2024